Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan

Por Ko, Andrew H
Publicado no Int J Nanomedicine (2016)

Erlotinib in the treatment of advanced pancreatic cancer

Por Kelley, Robin K, Ko, Andrew H
Publicado em 2008

Beyond first-line chemotherapy for advanced pancreatic cancer: An expanding array of therapeutic options?

Por Walker, Evan J, Ko, Andrew H
Publicado em 2014

A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer

Por Walker, Evan J., Simko, Jeffry P., Nakakura, Eric K., Ko, Andrew H.
Publicado no J Gastrointest Oncol (2014)

Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study

Por Walker, Evan J, Ko, Andrew H, Holly, Elizabeth A, Bracci, Paige M
Publicado no Int J Cancer (2014)

Statin use and risk of pancreatic cancer: Results from a large clinic-based case-control study

Por Walker, Evan J, Ko, Andrew H, Holly, Elizabeth A, Bracci, Paige M
Publicado no Cancer (2015)

Making Sense of Current and Emerging Therapies in Pancreatic Cancer: Balancing Benefit and Value

Por Ahn, Daniel H., Ko, Andrew H., Meropol, Neal J., Bekaii-Saab, Tanios S.
Publicado no Am Soc Clin Oncol Educ Book (2015)

Subtype Specific MEK – PI3 Kinase Feedback as a Therapeutic Target in Pancreatic Adenocarcinoma

Por Mirzoeva, Olga K., Collisson, Eric A., Schaefer, Peter M., Hann, Byron, Hom, Yun K., Ko, Andrew H., Korn, W. Michael
Publicado em 2013

Baseline Serum Albumin Is a Predictive Biomarker for Patients With Advanced Pancreatic Cancer Treated With Bevacizumab: A Pooled Analysis of 7 Prospective Trials of Gemcitabine-Bas...

Por Pant, Shubham, Martin, Ludmila K., Geyer, Susan, Wei, Lai, Van Loon, Katherine, Sommovilla, Nilli, Zalupski, Mark, Iyer, Renuka, Fogelman, David, Ko, Andrew H., Bekaii-Saab, Tanios
Publicado no Cancer (2014)

Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-...

Por Pant, Shubham, Martin, Ludmila K., Geyer, Susan, Wei, Lai, Van Loon, Katherine, Sommovilla, Nili, Zalupski, Mark, Iyer, Renuka, Fogelman, David, Ko, Andrew H., Bekaii-Saab, Tanios
Publicado no Am J Clin Oncol (2016)

Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors

Por Cho, Edward H., Wendel, Marco, Luttgen, Madelyn, Yoshioka, Craig, Marrinucci, Dena, Lazar, Daniel, Schram, Ethan, Nieva, Jorge, Bazhenova, Lyudmila, Morgan, Alison, Ko, Andrew H., Korn, W. Michael, Kolatkar, Anand, Bethel, Kelly, Kuhn, Peter
Publicado em 2012

Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer?: A pooled analysis of phase II trials of gemcitabine-containing doublets plu...

Por Van Loon, Katherine, Espinoza, Anne M., Fogelman, David R., Wolff, Robert A., Javle, Milind M., Iyer, Renuka V., Picozzi, Vincent J., Martin, Ludmila Katherine, Bekaii-Saab, Tanios, Tempero, Margaret A., Foster, Nathan R., Kim, George P., Ko, Andrew H.
Publicado em 2014

Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously tre...

Por Le, Dung T, Crocenzi, Todd S, Urum, Jennifer N, Lutz, Eric R, Laheru, Daniel A, Sugar, Elizabeth A, Vonderheide, Robert H, Fisher, George A, Ko, Andrew H, Murphy, Aimee L, McDougall, Katherine, Ferber, Sandy, Brockstedt, Dirk G, Jaffee, Elizabeth M
Publicado no J Immunother Cancer (2015)

Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy

Por Collisson, Eric A., Sadanandam, Anguraj, Olson, Peter, Gibb, William J., Truitt, Morgan, Gu, Shenda, Cooc, Janine, Weinkle, Jennifer, Kim, Grace E., Jakkula, Lakshmi, Feiler, Heidi S., Ko, Andrew H., Olshen, Adam B., Danenberg, Kathleen L., Tempero, Margaret A., Spellman, Paul T., Hanahan, Douglas, Gray, Joe W.
Publicado em 2011

Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas

Por Zill, Oliver A., Greene, Claire, Sebisanovic, Dragan, Siew, LaiMun, Leng, Jim, Vu, Mary, Hendifar, Andrew E., Wang, Zhen, Atreya, Chloe E., Kelley, Robin K., Van Loon, Katherine, Ko, Andrew H., Tempero, Margaret A., Bivona, Trever G., Munster, Pamela N., Talasaz, AmirAli, Collisson, Eric A.
Publicado no Cancer Discov (2015)

A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK Plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

Por Ko, Andrew H., Bekaii-Saab, Tanios, Van Ziffle, Jessica, Mirzoeva, Olga M., Joseph, Nancy, Talasaz, AmirAli, Kuhn, Peter, Tempero, Margaret A., Collisson, Eric A., Kelley, R. Kate, Venook, Alan P., Dito, Elizabeth, Ong, Anna, Ziyeh, Sharvina, Courtin, Ryan, Linetskaya, Regina, Tahiri, Sanaa, Korn, W. Michael
Publicado no Clin Cancer Res (2015)

Radioembolization with (90)Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a...

Por Fidelman, Nicholas, Kerlan, Robert K., Hawkins, Randall A., Pampaloni, Miguel, Taylor, Andrew G., Kohi, Maureen P., Kolli, K. Pallav, Atreya, Chloe E., Bergsland, Emily K., Kelley, R. Kate, Ko, Andrew H., Korn, W. Michael, Van Loon, Katherine, McWhirter, Ryan M., Luan, Jennifer, Johanson, Curt, Venook, Alan P.
Publicado no J Gastrointest Oncol (2016)

Fluid Biopsy in Patients with Metastatic Prostate, Pancreatic and Breast Cancers

Por Marrinucci, Dena, Bethel, Kelly, Kolatkar, Anand, Luttgen, Madelyn, Malchiodi, Michael, Baehring, Franziska, Voigt, Katharina, Lazar, Daniel, Nieva, Jorge, Bazhenova, Lyudmilda, Ko, Andrew H, Korn, W. Michael, Schram, Ethan, Coward, Michael, Yang, Xing, Metzner, Thomas, Lamy, Rachelle, Honnatti, Meghana, Yoshioka, Craig, Kunken, Joshua, Petrova, Yelena, Sok, Devin, Nelson, David, Kuhn, Peter
Publicado em 2012